DEXCOM, INC. Income Taxes Receivable, Current
DEXCOM, INC. (DXCM) had Income Taxes Receivable, Current of $12.50 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › and Others
us-gaap:IncomeTaxesReceivable · last filed 2026-07-30
- 2026-06-30: Income Taxes Receivable, Current $12.50M.
- 2026-03-31: Income Taxes Receivable, Current $6.20M.
- 2025-12-31: Income Taxes Receivable, Current $60.80M.
- 2025-09-30: Income Taxes Receivable, Current $48.60M.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2026-06-30 | $12.50M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $6.20M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $60.80M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $48.60M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $10.10M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $14.70M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $27.90M 10-K · filed 2026-02-12 |
| 2024-09-30 | $31.70M 10-Q · filed 2024-10-24 |
| 2024-06-30 | $53.50M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $6.20M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $13.60M 10-K · filed 2025-02-18 |
| 2023-09-30 | $2.80M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $5.00M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $15.70M 10-Q · filed 2023-04-27 |
| 2022-12-31 | $38.90M 10-K · filed 2024-02-08 |
| 2022-09-30 | $33.00M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $51.20M 10-Q · filed 2022-07-28 |
| 2021-12-31 | $2.30M 10-K · filed 2023-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |